Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study

J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e485-e487. doi: 10.1111/jdv.17279. Epub 2021 May 1.

J R Georgakopoulos¹, A Mufti¹, R Vender^{2

3}, V H Prajapati^{4

5

6

7

8

9}, J Yeung^{1

10

11

12}

¹ Division of Dermatology, Department of Medicine, University of Toronto, ON, Canada.
² Department of Dermatology, McMaster University, Hamilton, ON, Canada.
³ Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, ON, Canada.
⁴ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
⁵ Division of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
⁶ Division of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, AB, Canada.
⁷ Dermatology Research Institute, Calgary, AB, Canada.
⁸ Skin Health & Wellness Centre, Calgary, AB, Canada.
⁹ Probity Medical Research Inc, Calgary, AB, Canada.
¹⁰ Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
¹¹ Women's College Hospital, Toronto, ON, Canada.
¹² Probity Medical Research Inc, Waterloo, ON, Canada.

No abstract available

Publication types